SEC Form 4 · accession 0001127602-17-023365
UNITED THERAPEUTICS Corp · UTHR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Raymond Dwek
Director
Period of report
Jul 6, 2017
Accepted (ET)
Jul 7, 2017 · 4:09 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001082554
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 6, 2017 | M | 2,000 | $51.77 | A | 2,000 | D | |
| Common Stock | Jul 6, 2017 | D | 2,000 | $131.71 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Share Tracking Award | $51.77 | Jul 6, 2017 | M | 2,000 | D | Jun 28, 2011 | Jun 28, 2020 | Common Stock | 2,000 | 7,000 | D |
Explanation of responses
- F1This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person.